XTL BIOPHARMACEUTICALS-ADR (XTLB)

US98386D3070 - ADR

1.86  +0.01 (+0.35%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018
Revenue
YoY % growth
EBITDA
YoY % growth
-1.97M-2M
-1.52%		-1.71M
14.50%		-1.25M
26.90%		N/A
EBIT
YoY % growth
-2.02M-2.01M
0.50%		-1.71M
14.93%		-1.25M
26.90%		-790K
36.80%
Operating Margin
N/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A